P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 4, 1996, Pages 498-504

  Bültmann, Ralph ^a   Wittenburg, Henning ^a   Pause, Birgit ^a,d   Kurz, Gerhart ^b   Nickel, Peter ^c   Starke, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Pharmazeutisches Institut   (Germany)

^d Institut fur Biochemie I   (Germany)

Author keywords

Ecto nucleotidase; Guinea pig taenia coli; P(2X) purinoceptor; P(2Y) purinoceptor; P2 purinoceptor antagonists; Rat vas deferens; Suramin; Suramin derivatives

Indexed keywords

ADENOSINE 5' O (2 THIODIPHOSPHATE); ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; BST 101; CARBACHOL; NF 023; NUCLEOTIDASE; PURINE P2 RECEPTOR; RECEPTOR SUBTYPE; SURAMIN; UNCLASSIFIED DRUG; ADENOSINE 5'-O-(2-THIODIPHOSPHATE); ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; DRUG DERIVATIVE; ECTOATPASE; NF023; NUCLEOTIDE;

ANIMAL TISSUE; ARTICLE; COLON TENIA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; MALE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; VAS DEFERENS; VASODILATATION; ANIMAL; COLON; DRUG ANTAGONISM; DRUG EFFECT; GUINEA PIG; METABOLISM; MUSCLE CONTRACTION; MUSCLE RELAXATION; SMOOTH MUSCLE;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; COLON; GUINEA PIGS; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; RATS; RECEPTORS, PURINERGIC P2; STRUCTURE-ACTIVITY RELATIONSHIP; SURAMIN; THIONUCLEOTIDES; VAS DEFERENS;

EID: 0029658866     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00168442     Document Type: Article

References (32)

1. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58
2. Beukers MW, Kerkhof CJM, van Rhee MA, Ardanuy U, Gurgel C, Widjaja H, Nickel P, IJzerman AP, Soudijn W (1995) Suramin analogs, divalent cations and ATPγS as inhibitors of ecto-ATPase. Naunyn-Schmiedeberg's Arch Pharmacol 351:523-528
3. Blakeley AGH, Brockbank JE, Kelly SS, Petersen SA (1991) Effects of suramin on the concentration-response relationship of α,β-methylene ATP on the mouse vas deferens. J Auton Pharmacol 11:45-49
4. 2x-purinoceptors in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 348:684-687
5. 2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 349:74-80
6. 2x-purinoceptors in rat vas deferens. Br J Pharmacol 113:349-354
7. 2-purinoceptors in guinea-pig taenia coli. Naunyn-Schmiedeberg's Arch Pharmacol 353:445-451
8. 2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates. Naunyn-Schmiedeberg's Arch Pharmacol 354:481-490
9. 2Y subtypes. Drug Dev Res 31:206-219
10. 2 Receptor: subclassification and structure-activity relationships. Drug Dev Res 28:244-252
11. 2-purinoceptor response in smooth muscle cells of guinea-pig taenia caeci. Eur J Pharmacol 166:531-534
12. 2-purinoceptors in guinea-pig taenia coli. Naunyn-Schmiedeberg's Arch Pharmacol 351:107-110
13. 2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol 93:243-245
14. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines. Handbook of experimental pharmacology, vol 33. Springer, Berlin Heidelberg New York, pp 283-335
15. 2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol 99:617-621
16. 2x purinoceptors in rat vas deferens. Eur J Pharmacol 263:301-309
17. 2x purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens. Br J Pharmacol 115:177-185
18. 2 purinoceptor antagonists. Br J Pharmacol 115:2P
19. Kurz AK, Bültmann R, Driessen B, von Kügelgen I, Starke K (1994) Release of ATP in rat vas deferens: origin and role of calcium. Naunyn-Schmiedeberg's Arch Pharmacol 350:491-498
20. 2-Purinoceptor heterogeneity in guinea-pig taenia coli and rabbit vas deferens. Naunyn-Sehmiedeberg's Arch Pharmacol 353:R42
21. Mallard N, Marshall R, Sithers A, Spriggs B (1992) Suramin: a selective inhibitor of purinergic neurotransmission in rat isolated vas deferens. Eur J Pharmacol 220:1-10
22. Motulsky HJ, Ransnas LA (1987) Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J 1:365-374
23. Nickel P, Haack HJ, Widjaja H, Ardanuy U, Gurgel U, Düwel D, Loewe H, Raether W (1986) Potentielle Filarizide. Arzneim Forsch 36:1153-1157
24. Trezise DJ, Kennedy I, Humphrey PPA (1994) The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by α,β-methylene adenosine 5′-triphosphate. Br J Pharmacol 112:282-288
25. 2X receptors in the pithed rat. Eur J Pharmacol 175:207-210
26. 2 purinoceptors. Eur J Pharmacol 268:1-7
27. von Kügelgen I, Büllmann R, Starke K (1990) Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and surumin-insensitive components in the contractile effect of ATP. Naunyn-Schmiedeberg's Arch Pharmacol 342:198-205
28. Waud DR (1976) Analysis of dose-response relationships. In: Narahashi T, Bianchi CP (eds) Advances in general and cellular pharmacology, vol 1. Plenum, New York London, pp 145-178
29. 2-purinoceptor subtypes and ecto-nucleotidases. Naunyn-Schmiedeherg's Arch Pharmacol 353:R41
30. 2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue or trypan blue. Naunyn-Schmiedeberg's Arch Pharmacol 354:491-497
31. 2x-subtype. Drug Dev Res 31:336
32. 2x-purinoceptors in rat and hamster mesenteric arterial beds. Naunyn-Schmiedeberg's Arch Pharmacol 353:R41